{
  "title": "TBD | The Summer Vaccine of the Future",
  "description": "LYMErix, the first vaccine against Lyme, was pulled from the market amid poor sales and pressure from the public. Now, over 20 years later, a new vaccine is in late-stage trials.\nGuest: Cassandra Willyard\nHost: Lizzie O'Leary\nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "pubDate": "Sun, 04 Sep 2022 07:00:00 -0000",
  "itunes:title": "TBD | The Summer Vaccine of the Future",
  "itunes:episodeType": "full",
  "itunes:author": "Slate Podcasts",
  "itunes:image": "",
  "itunes:subtitle": "A new Lyme vaccine that's in late-stage trials would be the first in 20 years.",
  "itunes:summary": "LYMErix, the first vaccine against Lyme, was pulled from the market amid poor sales and pressure from the public. Now, over 20 years later, a new vaccine is in late-stage trials.\nGuest: Cassandra Willyard\nHost: Lizzie O'Leary\nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "content:encoded": "<p>LYMErix, the first vaccine against Lyme, was pulled from the market amid poor sales and pressure from the public. Now, over 20 years later, a new vaccine is in late-stage trials.</p><p>Guest: <a href=\"https://twitter.com/cwillyard\">Cassandra Willyard</a></p><p>Host: <a href=\"https://twitter.com/lizzieohreally\">Lizzie O'Leary</a></p><p> </p><p>Learn more about your ad choices. Visit <a href=\"https://megaphone.fm/adchoices\">megaphone.fm/adchoices</a></p>",
  "itunes:duration": 1255,
  "guid": 1000578078249,
  "enclosure": ""
}